More than 1,200 lawsuits allege Allergan Biocell breast implants caused anaplastic large cell lymphoma (ALCL) and other injuries, due to a defective textured surface area design.
At least 90 cases of ALCL have been reported in the Netherlands, according to the breast implant class action lawsuit against Allergan, which already faces hundreds of individual claims filed in the U.S.
Researchers found breast implant ALCL cases worldwide appeared to be exclusively linked to textured implants
Progression of the breast implant squamous cell carcinoma cases has reportedly led to some deaths, according to FDA Safety Communication.
A federal judge rejected a request by manufacturers to dismiss a Mentor MemoryShape lawsuit brought by a woman diagnosed with breast implant ALCL
The FDA is aware of 22 cases of squamous cell carcinoma and lymphomas linked to breast implants, which are unrelated to prior breast implant cancer warnings
Women continue to be diagnosed with BIA-ALCL and other health problems more than two years after Allergan's Biocell breast implants were recalled.
Requirements include a Boxed Warning about breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), and a mandatory patient decision checklist, among others
